Risperidone treatment of behavioral disturbances in outpatients with dementia

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 11, Issue 3, 1999, Pages 336-342

  Irizarry, Michael C ^a   Ghaemi, S Nassir ^b   Lee Cherry, Erica R ^b   Gomez Isla, Teresa ^b   Binetti, Giuliano ^b   Hyman, Bradley T ^b   Growdon, John H ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE; SEROTONIN UPTAKE INHIBITOR;

AGED; AGITATION; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; DEMENTIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MALE; OUTPATIENT; PRIORITY JOURNAL; PSYCHOSIS; TREATMENT OUTCOME;

EID: 0032818799     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.11.3.336     Document Type: Article

References (39)

1. Mega MS, Cummings JL, Fiorello T, et al: The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996; 46:130-135
2. Raskind MA: Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease. J Clin Psychiatry 1998; 59(suppl 9):28-32
3. Schneider LS, Pollock VE, Lyness SA: A meta-analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990; 38:553-563
4. Devanand DP, Levy SR: Neuroleptic treatment of agitation and psychosis in dementia. J Geriatr Psychiatry Neurol 1995; 8(suppl 1):S18-S27
5. Lanctot KL, Best TS, Mittmann N, et al: Efficacy and safety of neuroleptics in behavioral disorders associated with dementia. J Clin Psychiatry 1998; 59:550-561
6. Lieberman JA: Understanding the mechanism of action of atypical antipsychotic drugs. Br J Psychiatry 1993; 163(suppl 22):7-18
7. Ereshefsky L, Lacombe S: Pharmacological profile of risperidone. Can J Psychiatry 1993; 38(suppl 3):S80-S88
8. Chouinard G, Arnott W: Clinical review of risperidone. Can J Psychiatry 1993; 38(suppl 3):S89-S95
9. Muller-Spahn F: Risperidone in the treatment of chronic schizophrenic patients: an international double-blind parallel-group study versus haloperidol. Clin Neuropharmacol 1992; 15(suppl 1):90A-91A
10. Chapman MC, Woodley G, Khan BU: Risperidone for bipolar mania in the developmentally disabled (abstract). Presented at the American Psychiatric Association annual meeting, San Diego, CA, 1996
11. Bruun RD, Budman CL: Risperidone as a treatment for Tourette's syndrome. J Clin Psychiatry 1996; 57:29-31
12. Rich SS, Friedman JH, Ott BR: Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes. J Clin Psychiatry 1995; 56:556-559
13. Jeanblanc W, Davis YB: Risperidone for treating dementia-associated aggression (letter). Am J Psychiatry 1995; 152:1239
14. Madhusoonan S, Brenner R, Araujo L, et al: Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series. J Clin Psychiatry 1995; 56:514-518
15. Zarate CA, Baldessarini RJ, Siegel AJ, et al: Risperidone in the elderly: a pharmacoepidemiological study. J Clin Psychiatry 1997; 58:311-317
16. Kumar V: Use of atypical antipsychotic agents in geriatric patients: a review. International Journal of Geriatric Pyschopharmacology 1997; 1:15-23
17. Katz I, Brecher M, Clyde C: Risperidone in the treatment of psychosis and aggressive behavior in patients with dementia. Presented at the 36th annual meeting, American College of Neuropharmacology, Waikoloa, HI, 1997
18. Lindenmayer J-P: Risperidone: efficacy and side effects. J Clin Psychiatry monograph 1994; 12:53-58
19. Blessed G, Tomlinson BE, Roth M: The association between quantitative measures of dementia and of senile change in the grey matter of elderly subjects. Br J Psychiatry 1968; 114:797-811
20. Weintraub S: The record of independent living: an informant-completed measure of activities of daily living and behavior in elderly patients with cognitive impairment. Am J Alzheimer Care 1986; 1:35-39
21. Cohen-Mansfield J: Agitated behaviors in the elderly, II: preliminary results in the cognitively impaired. J Am Geriatr Soc 1986; 34:722-727
22. Dave M: Two cases of risperidone-induced neuroleptic malignant syndrome. Am J Psychiatry 1995; 152:1233-1234
23. Meterissian GB: Risperidone-induced neuroleptic malignant syndrome: a case report and review. Can J Psychiatry 1996; 41:52-54
24. Gleason PP, Conigliaro RL: Neuroleptic malignant syndrome with risperidone. Pharmacotherapy 1997; 17:617-621
25. Sachdev P, Kruk J, Kneebone M, et al: Clozapine-induced neuroleptic malignant syndrome: review and report of new cases. J Clin Psychopharmacol 1995; 15:365-371
26. Tsai G, Crisostomo G, Rosenblatt ML, et al: Neuroleptic malignant syndrome associated with clozapine treatment. Ann Clin Psychiatry 1995; 7:91-95
27. Thornberg SA, Ereshefsky L: Neuroleptic malignant syndrome associated with clozapine monotherapy. Pharmacotherapy 1993; 13:510-514
28. Simpson GM, Lindenmayer J-P: Extrapyramidal symptoms in patients treated with risperidone. J Clin Psychopharmacol 1997; 17:194-201
29. Miller CH, Umbricht DSG, Lieverman JA, et al: The prevalence and severity of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, or conventional antipsychotics. J Clin Psychiatry 1996; 59:69-75
30. Antunes PW, Preece C, Marek M, et al: Comparison of extra-pyramidal syndrome with haloperidol and risperidone. Presented at the American Psychiatric Association annual meeting, New York, NY, 1996
31. Ayd FJ: A Survey of drug-induced extrapyramidal reactions. JAMA 1961; 175:102-108
32. Sweet RA, Pollock BG: Neuroleptics in the elderly: guidelines for monitoring. Harvard Rev Psychiatry 1995; 2:327-335
33. Morgenstern H, Glazer W: Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Arch Gen Psychiatry 1993; 50:723-733
34. Leo R: Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 1996; 57:449-454
35. Gerber P, Lynd L: Selective serotonin-reuptake inhibitor-induced movement disorders. Ann Pharmacother 1998; 32: 692-698
36. Arya DK: Extrapyramidal symptoms with selective serotonin reuptake inhibitors. Br J Psychiatry 1994; 165:728-733
37. Risperidone: package insert. Physician's Desk Reference, 52nd edition. Montvale, NJ, Medical Economics Co, 1998
38. Kischka U, Mandir AS, Ghika J, et al: Electrophysiologic detection of extrapyramidal motor signs in Alzheimer's disease. Neurology 1993; 43:500-505
39. Chen JY, Stern Y, Sano M, et al: Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. Arch Neurol 1991; 48:1141-1143